Kisspeptin-10.
Kiss1-derived decapeptide — upstream regulator of GnRH and the reproductive axis.
Build your bag, then either book a consultation (an EU-licensed physician reviews your file — anything declined is refunded) or upload an existing Rx at checkout.
- ✓Magistral preparation — Directive 2001/83/EC Art. 5(1).
- ✓Patient-named prescription only — dispensed against a valid Rx.
- ✓EU-GMP Annex 1 Grade A/B cleanroom compounding.
- ✓Cold-chain shipping across EU/EEA — 2–5 working days.
About Kisspeptin-10.
Kisspeptin-10 is the active C-terminal decapeptide of kisspeptin, the master regulator of the hypothalamic-pituitary-gonadal axis. Loss-of-function mutations in the Kiss1 receptor (KISS1R) cause idiopathic hypogonadotropic hypogonadism.
Clinical research has examined kisspeptin in fertility and sexual-arousal contexts, with a particularly interesting profile for women with hypothalamic amenorrhea.
Kisspeptin binds KISS1R on hypothalamic GnRH neurons, triggering pulsatile GnRH release. This drives LH and FSH secretion from the pituitary and downstream sex-hormone production.
Subcutaneous or intravenous injection, typically 50–100 mcg per dose; protocols vary widely by indication.
Your physician sets the prescription. This is descriptive information, not a self-administration guide.
Lyophilised: store at 2–8 °C, protect from light. Once reconstituted: 2–8 °C, use within 30 days. Do not freeze.
- INN / Name
- Kisspeptin-10
- Form
- Lyophilised vial · subcutaneous injection
- Strength
- 5mg vial
- Manufacturing
- EU-GMP Annex 1 · Grade A/B
- Endotoxins
- European Pharmacopoeia 2.6.14 · LAL assay
- Identity & purity
- HPLC + MS · > 98%
- Cold chain
- Validated 2–8 °C, monitored end-to-end
- Regulatory basis
- Directive 2001/83/EC · Article 5(1)
2–5 working days
EU / EEA cold-chain delivery, 2–8 °C monitored end-to-end with digital temperature log. Tracking link sent on dispatch.
Magistral preparation
Patient-named preparation under Directive 2001/83/EC Article 5(1). Dispensed exclusively against a valid EU prescription.
EU prescription recognition
Prescriptions written in one EU member state are recognised in others under Directive 2011/24/EU on cross-border healthcare.